Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-000905
Accepted
2025-04-01 00:15:21
Documents
1
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-25-000905.txt   1780
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-286005 | Film No.: 25796324
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)